June 3 (Reuters) - U.S. Food and Drug Administration staff
released voting questions on Teva Pharmaceutical Industries
Ltd's long-acting opioid painkiller for a
panel of independent experts who will recommend to the agency
whether to approve the drug.
Read more
No comments:
Post a Comment